Review Article
The Clinical and Steroid-Free Remission of Fecal Microbiota Transplantation to Patients with Ulcerative Colitis: A Meta-Analysis
Table 2
Characteristics of the included studies.
| Study | Type | Country | Sample | Severity of the disease | Route | Fresh/frozen | Placebo type |
| Costello et al. [22] | RCT | Australia | 73 | Mild-moderate active UC | Transplantation | Frozen | Autologous FMT | Moayyedi et al. [23] | RCT | Canada | 75 | Active UC | Retention enema | Fresh and frozen | Consisting of 50 mL water | Rossen et al. [24] | RCT | Netherlands | 48 | Mild to moderate active UC | Nasoduodenal tube | Fresh | Autologous fecal microbiota | Paramsothy et al. [25] | RCT | Australia | 81 | Active UC | Infusion | Frozen | Isotonic saline adding brown food colourant, odourant, and glycerol cryoprotectant | Ishikawa et al. [26] | COHORT | Japan | 36 | Mild-to-severe active UC | Colonoscopy | Fresh | AFM monotherapy | Kump et al. 2017 [27] | COHORT | Austria | 27 | Refractory ulcerative colitis, chronic active ulcerative colitis | Endoscopy | Frozen | Antibiotic treatment |
|
|
Note: RCT: random controlled trials; COHORT: cohort studies; UC: ulcerative colitis; FMT: fecal microbiota transplantation; AFM: amoxicillin, fosfomycin, and metronidazole.
|